Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1967 2
1970 1
1971 5
1972 5
1973 7
1974 7
1975 6
1976 6
1977 4
1978 7
1979 5
1980 3
1981 5
1982 2
1983 5
1984 12
1985 8
1986 5
1987 21
1988 10
1989 12
1990 11
1991 11
1992 8
1993 14
1994 22
1995 12
1996 14
1997 14
1998 16
1999 22
2000 22
2001 21
2002 19
2003 30
2004 19
2005 22
2006 15
2007 20
2008 15
2009 17
2010 24
2011 27
2012 17
2013 22
2014 15
2015 14
2016 19
2017 14
2018 16
2019 16
2020 14
2021 14
2022 11
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

680 results

Results by year

Filters applied: . Clear all
Page 1
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy.
Li YR, Zhou Y, Kim YJ, Zhu Y, Ma F, Yu J, Wang YC, Chen X, Li Z, Zeng S, Wang X, Lee D, Ku J, Tsao T, Hardoy C, Huang J, Cheng D, Montel-Hagen A, Seet CS, Crooks GM, Larson SM, Sasine JP, Wang X, Pellegrini M, Ribas A, Kohn DB, Witte O, Wang P, Yang L. Li YR, et al. Among authors: larson sm. Cell Rep Med. 2021 Nov 16;2(11):100449. doi: 10.1016/j.xcrm.2021.100449. eCollection 2021 Nov 16. Cell Rep Med. 2021. PMID: 34841295 Free PMC article.
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma.
Larson SM, Walthers CM, Ji B, Ghafouri SN, Naparstek J, Trent J, Chen JM, Roshandell M, Harris C, Khericha M, Schweppe T, Berent-Maoz B, Gosliner SB, Almaktari A, Ceja MA, Allen-Auerbach MS, Said J, Nawaly K, Mead M, de Vos S, Young PA, Oliai C, Schiller GJ, Timmerman JM, Ribas A, Chen YY. Larson SM, et al. Cancer Discov. 2023 Mar 1;13(3):580-597. doi: 10.1158/2159-8290.CD-22-0964. Cancer Discov. 2023. PMID: 36416874 Free PMC article.
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.
Crees ZD, Rettig MP, Jayasinghe RG, Stockerl-Goldstein K, Larson SM, Arpad I, Milone GA, Martino M, Stiff P, Sborov D, Pereira D, Micallef I, Moreno-Jiménez G, Mikala G, Coronel MLP, Holtick U, Hiemenz J, Qazilbash MH, Hardy N, Latif T, García-Cadenas I, Vainstein-Haras A, Sorani E, Gliko-Kabir I, Goldstein I, Ickowicz D, Shemesh-Darvish L, Kadosh S, Gao F, Schroeder MA, Vij R, DiPersio JF. Crees ZD, et al. Among authors: larson sm. Nat Med. 2023 Apr;29(4):869-879. doi: 10.1038/s41591-023-02273-z. Epub 2023 Apr 17. Nat Med. 2023. PMID: 37069359 Free PMC article. Clinical Trial.
Larson SM. Larson SM. J Nucl Med. 2011 Nov;52(11):13N-20N. J Nucl Med. 2011. PMID: 22045711 Free article. No abstract available.
Vargas HA, Wassberg C, Fox JJ, Wibmer A, Goldman DA, Kuk D, Gonen M, Larson SM, Morris MJ, Scher HI, Hricak H. Vargas HA, et al. Among authors: larson sm. Radiology. 2015 Feb;274(2):625. Radiology. 2015. PMID: 25785291 No abstract available.
Pretargeting: A Path Forward for Radioimmunotherapy.
Cheal SM, Chung SK, Vaughn BA, Cheung NV, Larson SM. Cheal SM, et al. Among authors: larson sm. J Nucl Med. 2022 Sep;63(9):1302-1315. doi: 10.2967/jnumed.121.262186. J Nucl Med. 2022. PMID: 36215514 Free article. Review.
Larson SM. Larson SM. J Nucl Med. 2010 Sep;51(9):19N-25N. J Nucl Med. 2010. PMID: 20810752 Free article. No abstract available.
Radioimmunotherapy of human tumours.
Larson SM, Carrasquillo JA, Cheung NK, Press OW. Larson SM, et al. Nat Rev Cancer. 2015 Jun;15(6):347-60. doi: 10.1038/nrc3925. Nat Rev Cancer. 2015. PMID: 25998714 Free PMC article. Review.
Moving Toward a Cure for Myeloma.
Mateos MV, Nooka AK, Larson SM. Mateos MV, et al. Among authors: larson sm. Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-12. doi: 10.1200/EDBK_349603. Am Soc Clin Oncol Educ Book. 2022. PMID: 35623025 Free article.
Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies.
Kramer K, Pandit-Taskar N, Kushner BH, Zanzonico P, Humm JL, Tomlinson U, Donzelli M, Wolden SL, Haque S, Dunkel I, Souweidane MM, Greenfield JP, Tickoo S, Lewis JS, Lyashchenko SK, Carrasquillo JA, Chu B, Horan C, Larson SM, Cheung NV, Modak S. Kramer K, et al. Among authors: larson sm. J Hematol Oncol. 2022 Nov 12;15(1):165. doi: 10.1186/s13045-022-01383-4. J Hematol Oncol. 2022. PMID: 36371226 Free PMC article. Clinical Trial.
680 results